A double-blind, placebo-controlled trial of topiramate for pathological gambling

References

• Barratt ES, Patton JH. 1983. Impulsivity: Cognitive, behavioural, and psychophysiological correlate. Zuckerman M. Biological basis of sensation seeking, impulsivity, and anxiety. Hillside, NJ: Lawrence Erlbaum Associates. 77–122.
   Google Scholar
• Berlin HA. 2008. Antiepileptic drugs for the treatment of impulsivity. Curr Psychiatry Rev 4:114–136.
   Google Scholar
• Berlin HA, Rolls ET, Kischka U. 2004. Impulsivity, time perception, emotion and reinforcement sensitivity in patients with orbitofrontal cortex lesions. Brain 127(Pt 5):1108–1126.
   PubMedGoogle Scholar
• Berlin HA, Rolls ET, Iversen SD. 2005. Borderline personality disorder, impulsivity, and the orbitofrontal cortex. Am J Psychiatry 162:2360–2373.
   PubMed Web of Science ®Google Scholar
• Blanco C, Petkova E, Ibanez A, Saiz-Ruiz J. 2002. A pilot placebo-controlled study of fluvoxamine for pathological gambling. Ann Clin Psychiatry 14:9–15.
   PubMedGoogle Scholar
• Blanco C, Potenza MN, Kim SW, Ibanez A, Zaninelli R, Saiz-Ruiz J, Grant JE. 2009. A pilot study of impulsivity and compulsivity in pathological gambling. Psychiatry Res 167(1–2): 161–168.
   PubMed Web of Science ®Google Scholar
• Brewer JA, Potenza MN. 2008. The neurobiology and genetics of impulse control disorders: relationships to drug addictions. Biochem Pharmacol 75:63–75.
   PubMed Web of Science ®Google Scholar
• Carter WP, Hudson JI, Lalonde JK, Pindyck L, McElroy SL, Pope HG Jr. 2003. Pharmacologic treatment of binge eating disorder. Int J Eat Disord 34(Suppl):S74–88.
   Google Scholar
• Cunningham-Williams RM, Grucza RA, Cottler LB, Womack SB, Books SJ, Przybeck TR, . 2005. Prevalence and predictors of pathological gambling: results from the St. Louis personality, health and lifestyle (SLPHL) study. J Psychiatr Res 39:377–390.
   PubMed Web of Science ®Google Scholar
• Cunningham-Williams RM, Abdallah AB, Callahan C, Cottler L. 2007. Problem gambling and violence among community-recruited female substance abusers. Psychol Addict Behav 21: 239–243.
   PubMed Web of Science ®Google Scholar
• Dannon PN, Lowengrub K, Gonopolski Y, Musin E, Kotler M. 2005. Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study. Clin Neuropharmacol 28:6–10.
   PubMed Web of Science ®Google Scholar
• Dannon PN, Lowengrub K, Musin E, Gonopolsky Y, Kotler M. 2007. 12-month follow-up study of drug treatment in pathological gamblers: a primary outcome study. J Clin Psychopharmacol 27:620–624.
   PubMed Web of Science ®Google Scholar
• Dickson-Swift VA, James EL, Kippin S. 2005. The experience of living with a problem gambler: spouse and partners speak out. J Gambl Issues 13:1–22.
   Google Scholar
• Evenden J. 1999a. Impulsivity: a discussion of clinical and experimental findings. J Psychopharmacol 13:180–192.
   PubMed Web of Science ®Google Scholar
• Evenden JL. 1999b. Varieties of impulsivity. Psychopharmacology (Berlin) 146:348–361.
   PubMed Web of Science ®Google Scholar
• Fineberg NA, Potenza MN, Chamberlain SR, Berlin HA, Menzies L, Bechara A, . 2010. Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology 35: 591–604.
   PubMed Web of Science ®Google Scholar
• First MB, Spitzer RL, Gibbon MG, Williams JBW. 2002. Structured Clinical Interview for DSM-IV-TR Axis I Disorders – Patient Edition (SCID-I/P, 11/2002 revision). New York, NY: Biometrics Research Department, New York State Psychiatric Institute.
   Google Scholar
• Fong T, Kalechstein A, Bernhard B, Rosenthal R, Rugle L. 2008. A double-blind, placebo-controlled trial of olanzapine for the treatment of video poker pathological gamblers. Pharmacol Biochem Behav 89:298–303.
   PubMed Web of Science ®Google Scholar
• Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS. 1989a. The Yale-Brown Obsessive Compulsive Scale. II. Validity. Arch Gen Psychiatry 46: 1012–1016.
   PubMed Web of Science ®Google Scholar
• Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, . 1989b. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 46:1006–1011.
   PubMed Web of Science ®Google Scholar
• Goudriaan AE, Oosterlaan J, de Beurs E, Van den Brink W. 2004. Pathological gambling: a comprehensive review of biobehavioral findings. Neurosci Biobehav Rev 28: 123–141.
   PubMed Web of Science ®Google Scholar
• Grant JE, Kim SW, Potenza MN, Blanco C, Ibanez A, Stevens L, . 2003. Paroxetine treatment of pathological gambling: a multi-centre randomized controlled trial. Int Clin Psychopharmacol 18:243–249.
   PubMed Web of Science ®Google Scholar
• Grant JE, Steinberg MA, Kim SW, Rounsaville BJ, Potenza MN. 2004. Preliminary validity and reliability testing of a structured clinical interview for pathological gambling. Psychiatry Res 128:79–88.
   PubMed Web of Science ®Google Scholar
• Grant JE, Brewer JA, Potenza MN. 2006. The neurobiology of substance and behavioral addictions. CNS Spectr 11: 924–930.
   PubMed Web of Science ®Google Scholar
• Grant JE, Kim SW, Hartman BK. 2008. A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges. J Clin Psychiatry 69:783–789.
   PubMed Web of Science ®Google Scholar
• Grant JE, Odlaug BL, Potenza MN, Hollander E, Kim SW. 2010. A Multi-center double-blind, placebo-controlled study of the opioid antagonist nalmefene in the treatment of pathological gambling. Br J Psychiatry 197:330–331.
   PubMed Web of Science ®Google Scholar
• Guy W. 1976. ECDEU Assessment Manual for Psychopharmacology. Washington, DC: National Institute of Health, Psychopharmacology Research Branch.
   Google Scholar
• Hamilton M. 1959. The assessment of anxiety states by rating. Br J Med Psychol 32:50–55.
   PubMed Web of Science ®Google Scholar
• Hamilton M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62.
   PubMed Web of Science ®Google Scholar
• Harvey PD, Greenberg BR, Serper MR. 1989. The affective lability scales: development, reliability, and validity. J Clin Psychol 45:786–793.
   PubMed Web of Science ®Google Scholar
• Hollander E, Berlin HA. 2008. Impulse-control disorders measures. Rush A, First MB, Blacker D. Handbook of psychiatric measures. 2nd. Washington, DC: American Psychiatric Publishing, Inc. 667–686.
   Google Scholar
• Hollander E, DeCaria CM, Mari E, Wong CM, Mosovich S, Grossman R, Begaz T. 1998. Short-term single-blind fluvoxamine treatment of pathological gambling. Am J Psychiatry 155:1781–1783.
   PubMed Web of Science ®Google Scholar
• Hollander E, DeCaria CM, Finkell JN, Begaz T, Wong CM, Cartwright C. 2000. A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling. Biol Psychiatry 47:813–817.
   PubMed Web of Science ®Google Scholar
• Hollander E, Pallanti S, Allen A, Sood E, Baldini Rossi N. 2005. Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? Am J Psychiatry 162:137–145.
   PubMed Web of Science ®Google Scholar
• Hollander E, Berlin HA, Stein D. 2008. Impulse-control disorders not elsewhere classified. Hales RE, Yudofsky SC, Gabbard GO. American Psychiatric Publishing Texbook of Psychiatry, 5th. Arlington, VA: American Psychiatric Publishing.
   Google Scholar
• Hoopes SP, Reimherr FW, Hedges DW, Rosenthal NR, Kamin M, Karim R, . 2003. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binge and purge measures. J Clin Psychiatry 64:1335–1341.
   PubMed Web of Science ®Google Scholar
• Johnson BA, Ait-Daoud N, Bowden CL, DiClemente CC, Roache JD, Lawson K, . 2003. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet 361:1677–1685.
   PubMed Web of Science ®Google Scholar
• Johnson BA, Ait-Daoud N, Akhtar FZ, Ma JZ. 2004. Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial. Arch Gen Psychiatry 61:905–912.
   PubMed Web of Science ®Google Scholar
• Johnson BA, Rosenthal N, Capece JA, Wiegand F, Mao L, Beyers K, . 2007. Topiramate for treating alcohol dependence: a randomized controlled trial. J Am Med Assoc 298: 1641–1651.
   PubMed Web of Science ®Google Scholar
• Kampman KM, Pettinati H, Lynch KG, Dackis C, Sparkman T, Weigley C, O'Brien CP. 2004. A pilot trial of topiramate for the treatment of cocaine dependence. Drug Alcohol Depend 75:233–240.
   PubMed Web of Science ®Google Scholar
• Karila L, Gorelick D, Weinstein A, Noble F, Benyamina A, Coscas S, . 2008. New treatments for cocaine dependence: a focused review. Int J Neuropsychopharmacol 11: 425–438.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Hwang I, LaBrie R, Petukhova M, Sampson NA, Winters KC, Shaffer HJ. 2008. DSM-IV pathological gambling in the National Comorbidity Survey Replication. Psychol Med 38:1351–1360.
   PubMed Web of Science ®Google Scholar
• Kim SW. 1998. Opioid antagonists in the treatment of impulse-control disorders. J Clin Psychiatry 59:159–164.
   PubMed Web of Science ®Google Scholar
• Kim SW, Grant JE. 2001. An open naltrexone treatment study in pathological gambling disorder. Int Clin Psychopharmacol 16:285–289.
   PubMed Web of Science ®Google Scholar
• Kim SW, Grant JE, Adson DE, Shin YC. 2001. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry 49:914–921.
   PubMed Web of Science ®Google Scholar
• Kim SW, Grant JE, Adson DE, Shin YC, Zaninelli R. 2002. A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. J Clin Psychiatry 63:501–507.
   PubMed Web of Science ®Google Scholar
• Leombruni P, Lavagnino L, Fassino S. 2009. Treatment of obese patients with binge eating disorder using topiramate: a review. Neuropsychiatr Dis Treat 5:385–392.
   PubMed Web of Science ®Google Scholar
• Lesieur H. 1998. Costs and treatment of pathological gambling. Ann Am Acad Pol Soc Sci 556:157–171.
   Web of Science ®Google Scholar
• Lesieur HR, Blume SB. 1987. The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers. Am J Psychiatry 144:1184–1188.
   PubMed Web of Science ®Google Scholar
• McElroy SL, Keck PE Jr. 2009. Topiramate. Schatzberg A, Nemeroff C. The American Psychiatric Publishing Texbook of Psychopharmacology. 4th. Washington, DC: American Psychiatric Publishing.
   Google Scholar
• McElroy SL, Arnold LM, Shapira NA, Keck PE Jr, Rosenthal NR, Karim MR, . 2003. Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial. Am J Psychiatry 160:255–261.
   PubMed Web of Science ®Google Scholar
• McElroy SL, Hudson JI, Capece JA, Beyers K, Fisher AC, Rosenthal NR. 2007. Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study. Biol Psychiatry 61:1039–1048.
   PubMed Web of Science ®Google Scholar
• McElroy SL, Nelson EB, Welge JA, Kaehler L, Keck PE Jr. 2008. Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial. J Clin Psychiatry 69:433–440.
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Mancini DA, McCann S, Srinivasan J, Sagman D, Kennedy SH. 2002. Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study. Bipolar Disord 4:207–213.
   PubMed Web of Science ®Google Scholar
• Montgomery SA, Asberg M. 1979. A new depression scale desig ned to be sensitive to change. Br J Psychiatry 134:382–389.
   PubMed Web of Science ®Google Scholar
• Muelleman RL, DenOtter T, Wadman MC, Tran TP, Anderson J. 2002. Problem gambling in the partner of the emergency department patient as a risk factor for intimate partner violence. J Emerg Med 23:307–312.
   PubMed Web of Science ®Google Scholar
• Nicolato R, Romano-Silva MA, Correa H, Salgado JV, Teixeira AL. 2007. Lithium and topiramate association in the treatment of comorbid pathological gambling and bipolar disorder. Aust NZ J Psychiatry 41:628.
   PubMed Web of Science ®Google Scholar
• Pallanti S, DeCaria CM, Grant JE, Urpe M, Hollander E. 2005. Reliability and validity of the pathological gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS). J Gambl Stud 21:431–443.
   PubMed Web of Science ®Google Scholar
• Patton JH, Stanford MS, Barratt ES. 1995. Factor structure of the Barratt impulsiveness scale. J Clin Psychol 51:768–774.
   PubMed Web of Science ®Google Scholar
• Petry NM. 2007. Gambling and substance use disorders: current status and future directions. Am J Addict 16:1–9.
   PubMed Web of Science ®Google Scholar
• Petry NM, Stinson FS, Grant BF. 2005. Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 66:564–574.
   PubMed Web of Science ®Google Scholar
• Potenza MN. 2006. Should addictive disorders include non-substance-related conditions? Addiction 101(Suppl 1):142–151.
   PubMedGoogle Scholar
• Potenza MN. 2008. Review. The neurobiology of pathological gambling and drug addiction: an overview and new findings. Phil Trans R Soc London B Biol Sci 363:3181–3189.
   PubMed Web of Science ®Google Scholar
• Potenza MN. 2009. Non-substance and substance addictions. Addiction 104:1016–1017.
   PubMed Web of Science ®Google Scholar
• Reis AD, Castro LA, Faria R, Laranjeira R. 2008. Craving decrease with topiramate in outpatient treatment for cocaine dependence: an open label trial. Rev Bras Psiquiatr 30:132–135.
   PubMed Web of Science ®Google Scholar
• Saiz-Ruiz J, Blanco C, Ibanez A, Masramon X, Gomez MM, Madrigal M, Diez T. 2005. Sertraline treatment of pathological gambling: a pilot study. J Clin Psychiatry 66:28–33.
   PubMed Web of Science ®Google Scholar
• Sheehan DV. 1983. The anxiety disease. New York: Charles Scribner & Sons.
   Google Scholar
• Shinn AK, Greenfield SF. 2010. Topiramate in the treatment of substance-related disorders: a critical review of the literature. J Clin Psychiatry 71:634–648.
   PubMed Web of Science ®Google Scholar
• Sood ED, Pallanti S, Hollander E. 2003. Diagnosis and treatment of pathologic gambling. Curr Psychiatry Rep 5:9–15.
   PubMedGoogle Scholar
• Thurstone L. 1953. Examiner manual for the Thurstone Temperament Schedule. Chicago, IL: Science Research Associates.
   Google Scholar
• Volkow ND, Fowler JS. 2000. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex 10:318–325.
   PubMed Web of Science ®Google Scholar
• Wareham JD, Potenza MN. 2010. Pathological gambling and substance use disorders. Am J Drug Alcohol Abuse 36:242–247.
   PubMed Web of Science ®Google Scholar
• Young RC, Biggs JT, Ziegler VE, Meyer DA. 1978. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133:429–35.
   PubMed Web of Science ®Google Scholar